These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 15978215)

  • 1. Effects of irbesartan on the expression of matrix metalloproteinase-2/tissue inhibitor of metalloproteinase-2 in streptozotocin-induced diabetic rat kidney.
    Liu BC; Xu Y; Ma KL; Huang HQ; Yin LF; Liu DG
    Chin Med J (Engl); 2005 Jun; 118(12):1040-4. PubMed ID: 15978215
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
    Sun SZ; Wang Y; Li Q; Tian YJ; Liu MH; Yu YH
    Chin Med J (Engl); 2006 May; 119(10):814-21. PubMed ID: 16732983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Influence of irbesartan on renal hypertrophy and thickening of glomerular basement-membrane in streptozotocin-induced diabetic rats].
    Liu BC; Luo DD; Sun J; Ma KL; Ruan XZ
    Zhonghua Nei Ke Za Zhi; 2003 May; 42(5):320-3. PubMed ID: 12882713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of irbesartan on the antioxidant defence system and nitric oxide release in diabetic rat kidney.
    Anjaneyulu M; Chopra K
    Am J Nephrol; 2004; 24(5):488-96. PubMed ID: 15353911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irbesartan ameliorates diabetic nephropathy by reducing the expression of connective tissue growth factor and alpha-smooth-muscle actin in the tubulointerstitium of diabetic rats.
    Ren X; Guan G; Liu G; Liu G
    Pharmacology; 2009; 83(2):80-7. PubMed ID: 19065061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of blocking the renin-angiotensin system on expression and translocation of protein kinase C isoforms in the kidney of diabetic rats.
    Zhang L; Ma J; Gu Y; Lin S
    Nephron Exp Nephrol; 2006; 104(3):e103-11. PubMed ID: 16837815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic and local effects of angiotensin II blockade in experimental diabetic nephropathy.
    Vieitez P; Gómez O; Uceda ER; Vera ME; Molina-Holgado E
    J Renin Angiotensin Aldosterone Syst; 2008 Jun; 9(2):96-102. PubMed ID: 18584585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of irbesartan on nitric oxide system in the heart of diabetic rats].
    Qian XX; Chen YM; Wu WK; Liu Y; Zhou B; Liu JL; Chen L
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Sep; 26(9):1359-62. PubMed ID: 16982456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Irbesartan on Chemerin in the Renal Tissues of Diabetic Rats.
    Yu QX; Zhang H; Xu WH; Hao F; Liu SL; Bai MM; Mu JW; Zhang HJ
    Kidney Blood Press Res; 2015; 40(5):467-77. PubMed ID: 26394118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of emodin and irbesartan on ventricular fibrosis in Goldblatt hypertensive rats.
    Chen Q; Pang L; Huang S; Lei W; Huang D
    Pharmazie; 2014 May; 69(5):374-8. PubMed ID: 24855831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valsartan inhibited HIF-1α pathway and attenuated renal interstitial fibrosis in streptozotocin-diabetic rats.
    Tang L; Yi R; Yang B; Li H; Chen H; Liu Z
    Diabetes Res Clin Pract; 2012 Jul; 97(1):125-31. PubMed ID: 22377232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy.
    Van Linthout S; Seeland U; Riad A; Eckhardt O; Hohl M; Dhayat N; Richter U; Fischer JW; Böhm M; Pauschinger M; Schultheiss HP; Tschöpe C
    Basic Res Cardiol; 2008 Jul; 103(4):319-27. PubMed ID: 18347835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved gastric emptying in diabetic rats by irbesartan via decreased serum leptin and ameliorated gastric microcirculation.
    He L; Sun Y; Zhu Y; Ren R; Zhang Y; Wang F
    Genet Mol Res; 2014 Sep; 13(3):7163-72. PubMed ID: 25222222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal expression of proto-oncogene Ets-1 on matrix remodeling in experimental diabetic nephropathy.
    Liu DX; Liu XM; Su Y; Zhang XJ
    Acta Histochem; 2011 Sep; 113(5):527-33. PubMed ID: 20598359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effects of irbesartan and alpha lipoic acid in STZ-induced diabetic nephropathy in rats.
    Kanter M; Sen S; Donmez S; Aktas C; Ustundag S; Erboga M
    Ren Fail; 2010 May; 32(4):498-505. PubMed ID: 20446791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contributions of inflammation and cardiac matrix metalloproteinase activity to cardiac failure in diabetic cardiomyopathy: the role of angiotensin type 1 receptor antagonism.
    Westermann D; Rutschow S; Jäger S; Linderer A; Anker S; Riad A; Unger T; Schultheiss HP; Pauschinger M; Tschöpe C
    Diabetes; 2007 Mar; 56(3):641-6. PubMed ID: 17327431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pleiotropic actions of rosuvastatin confer renal benefits in the diabetic Apo-E knockout mouse.
    Giunti S; Calkin AC; Forbes JM; Allen TJ; Thomas MC; Cooper ME; Jandeleit-Dahm KA
    Am J Physiol Renal Physiol; 2010 Sep; 299(3):F528-35. PubMed ID: 20554645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of angiotensin II receptor antagonist on rat podocyte injury in early diabetic nephropathy].
    Long HB; Zhong J; Wei LB; Zhou WD; Xu ZZ
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Apr; 27(4):505-8. PubMed ID: 17545045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dose-effect relationship of irbsartan with the changes in the renal tissue structure in diabetic rats].
    Tang JL; Shen J; Liu S; Fan YF; Xie CH
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):1066-8. PubMed ID: 20501395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.
    Han SY; Jee YH; Han KH; Kang YS; Kim HK; Han JY; Kim YS; Cha DR
    Nephrol Dial Transplant; 2006 Sep; 21(9):2406-16. PubMed ID: 16728425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.